Tranilast is an antiallergic active pharmaceutical ingredient primarily used in pharmaceutical manufacturing. It was first approved in Japan and South Korea for bronchial asthma, with additional indications for keloid and hypertrophic scars added later.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Tranilast?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
7-amino-3-chloro-3-cephem-4-carboxylic acid
pharmaceutical raw material
Cefaclor
pharmaceutical raw material
(−)-nicotine
pharmaceutical raw material
Sodium salicylate
pharmaceutical raw material
(E)-N-(3-Methoxyphenyl)-3-phenyl-2-propenamide
pharmaceutical intermediate
The international HS code for Tranilast (CAS 53902-12-8) is 2924.29.
2924.29
2924 29 70
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid
NZHGWWWHIYHZNX-CSKARUKUSA-N
COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC
Sourcing Tranilast?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.